Company intelligence / Profile preview

Life Sciences Opportunity Fund II

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Life Sciences Opportunity Fund II is a venture capital fund focused on growth-stage investments within the life sciences, biotechnology, and healthcare sectors. Managed by Signet Healthcare Partners, the fund provides capital to small and mid-sized companies to support clinical development, product commercialization, and strategic expansion. The fund's investment strategy emphasizes companies with established products or advanced-stage clinical assets in areas such as specialty pharmaceuticals and medical technology. Originally sponsored by the Sanders Morris Harris Group, the fund has played a significant role in financing innovative healthcare companies like Bioject Medical Technologies.

Industry: Investors

Beyond the preview

Go deeper on Life Sciences Opportunity Fund II.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Life Sciences Opportunity Fund II.

Explore the full profile